Research Interest

Pathophysiology and the pharmacological therapy of diet- induced insulin resistance and the related cardiovascular risk factors, mainly organ-related ischemic events. Specifically, investigation of the pharmacological potential of selective ligands of the enzyme GSK-3beta, nuclear receptors PPAR and erythropoietin derivatives in in vivo models of ischemic diseases (myocardial infarction, stroke, acute kidney injury), shock (hemorrhagic and endotoxic shock) and diet-induced (mainly sugar-induced) dysmetabolism.

Massimo Collino

Associate Professor

 

  • :+390116707955

  • DEPARTMENT

    Department of Drug Science and Technology,
    University of Turin    


  • COUNTRYITALY